Cargando…

Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C

Vitamin D serum levels seem to influence antiviral response in chronic hepatitis C. Vitamin D pathway is controlled by genes presenting functional single nucleotide polymorphisms (SNPs). Data regarding the association between these polymorphisms and the rate of sustained viral response (SVR) followi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falleti, Edmondo, Cmet, Sara, Fabris, Carlo, Fattovich, Giovanna, Cussigh, Annarosa, Bitetto, Davide, Ceriani, Elisa, Lenisa, Ilaria, Dissegna, Denis, Ieluzzi, Donatella, Rostello, Anna, Pirisi, Mario, Toniutto, Pierluigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828272/ https://www.ncbi.nlm.nih.gov/pubmed/24244713 http://dx.doi.org/10.1371/journal.pone.0080764

Ejemplares similares

Mycophenolate Interruption Restores Anti-SARS-CoV-2 Vaccine Immunogenicity in Unresponsive Liver Transplant Recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2023)

Low risk of nosocomial severe acute respiratory syndrome-coronavirus-2 infection in patients with liver disease admitted to a hepatology unit at an academic hospital: A single-center experience
por: Toniutto, Pierluigi, et al.
Publicado: (2022)

Baseline Predictors of the Long-Term Insufficient Biochemical Response in Patients with Autoimmune Hepatitis: A Single Center Experience
por: Toniutto, Pierluigi, et al.
Publicado: (2023)

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2022)

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation
por: Toniutto, Pierluigi, et al.
Publicado: (2008)

Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study
por: Kondili, Loreta A., et al.
Publicado: (2017)

Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study
por: Kondili, Loreta A., et al.
Publicado: (2018)

Dissociating Slow Responses From Slow Responding
por: Salunkhe, Gayatri, et al.
Publicado: (2020)

PB2525: A FOUR YEARS’ EXPERIENCE OF UNIVERSAL NEWBORN SCREENING FOR HAEMOGLOBIN DISORDERS IN UDINE, FVG, NORTHERN ITALY
por: Cmet, Sara, et al.
Publicado: (2023)

A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation
por: Mio, Catia, et al.
Publicado: (2020)

Special Issue “New Therapies of Liver Diseases”
por: Toniutto, Pierluigi
Publicado: (2022)

Tentative T Cells: Memory Cells Are Quick to Respond, but Slow to Divide
por: Whitmire, Jason K., et al.
Publicado: (2008)

The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management
por: Faloppi, Luca, et al.
Publicado: (2014)

Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Drug–Drug Interactions in Italian Patients with Chronic Hepatitis C Treated with Pangenotypic Direct Acting Agents: Insights from a Real-World Study
por: Mangia, Alessandra, et al.
Publicado: (2021)

Human memory T cells with a naïve phenotype accumulate with aging and respond to persistent viruses
por: Pulko, Vesna, et al.
Publicado: (2016)

Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib
por: Howell, Jessica A., et al.
Publicado: (2017)

Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis
por: Alavian, Seyed Moayed, et al.
Publicado: (2011)

Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B
por: Choe, Jae Young, et al.
Publicado: (2017)

Mpox virus infects and injures human kidney organoids, but responding to antiviral treatment
por: Li, Pengfei, et al.
Publicado: (2023)

Tumor characteristics of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C: Comparative analysis with antiviral therapy-naive patients
por: Fouad, Magdy, et al.
Publicado: (2021)

Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients
por: Marascio, Nadia, et al.
Publicado: (2016)

Slow, slow, slow, quick quick, slow
Publicado: (1976)

Context-Specific Habituation: A Review
por: Dissegna, Andrea, et al.
Publicado: (2021)

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
por: Baranauskaite, Asta, et al.
Publicado: (2011)

Naive CD8+ T cells from ART respond to primary vaccination against autologous HIV-1 antigen
por: Smith, Kellie N, et al.
Publicado: (2012)

The TCR’s sensitivity to self-peptide–MHC dictates the ability of naïve CD8(+) T cells to respond to foreign antigens
por: Fulton, Ross B., et al.
Publicado: (2014)

Characterization of Metabolic Parameters in Responders and Nonresponders Treated with Canagliflozin Monotherapy in Drug-naive Subjects with Type 2 Diabetes
por: Kutoh, Eiji, et al.
Publicado: (2018)

Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies
por: Lafont, Bernard A.P., et al.
Publicado: (2020)

Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim Assessment
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2022)

Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection
por: Vezys, Vaiva, et al.
Publicado: (2006)

Identification of HCV Resistant Variants against Direct Acting Antivirals in Plasma and Liver of Treatment Naïve Patients
por: Raj, V. Stalin, et al.
Publicado: (2017)

Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients
por: Pereira, Grenda Leite, et al.
Publicado: (2019)

The effect of different direct antivirals on hepatic steatosis in nondiabetic and naïve hepatitis C-infected Egyptian patients
por: El-Ghandour, Ahmed, et al.
Publicado: (2023)

Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals
por: Lee, Hye Won, et al.
Publicado: (2019)

Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study
por: Vaghi, Gloria, et al.
Publicado: (2020)

Procedure‐related bleeding risk in patients with cirrhosis and severe thrombocytopenia
por: Alvaro, Domenico, et al.
Publicado: (2021)

Critical slowing down may account for the robustness of development
por: Zhang, Weiting, et al.
Publicado: (2022)

Italian Real-World Analysis of the Impact of Polypharmacy and Aging on the Risk of Multiple Drug–Drug Interactions (DDIs) in HCV Patients Treated with Pangenotypic Direct-Acting Antivirals (pDAA)
por: Fagiuoli, Stefano, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8q5ncu9t1cib84uspshf4csrgh